Search research articles
Contact Us
Filters
Showing results (121-130 of 271) with videos related to
Page
of 28
Sort By:
Journal of Pharmaceutical and Biomedical Analysis
|
September 24, 2013
Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS
Jia-Hua Zheng, Louis A Guida, Caitlin Rower, et al.
Contemporary Clinical Trials
|
July 10, 2026
Life-steps for PrEP nurse-delivered adherence intervention: Protocol for a multisite randomized clinical trial
Marc Puccinelli, Kenneth H Mayer, Juan A Esquivel-Mendoza, et al.
Plos One
|
January 10, 2018
Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial
Sanjiv M Baxi, Eric Vittinghoff, Peter Bacchetti, et al.
Open Forum Infectious Diseases
|
September 29, 2021
Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIV
Jose R Castillo-Mancilla, Mary Morrow, Ryan P Coyle, et al.
AIDS (London, England)
|
June 15, 2021
Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence
Mary Morrow, Samantha MaWhinney, Ryan P Coyle, et al.
Frontiers in Reproductive Health
|
June 11, 2024
Establishing adherence-concentration-efficacy thresholds of TDF-FTC pre-exposure prophylaxis for HIV prevention in African women: a protocol for the Women TDF-FTC Benchmark Study
Linxuan Wu, Matilda Saina, Clare Brown, et al.
Journal of Neurovirology
|
January 9, 2019
Self-initiated continuation of and adherence to HIV pre-exposure prophylaxis (PrEP) after PrEP demonstration project roll-off in men who have sex with men: associations with risky decision making, impulsivity/disinhibition, and sensation seeking
Martin Hoenigl, Erin Morgan, Donald Franklin, et al.
Journal of the International AIDS Society
|
April 8, 2025
Exploring potential drug-drug interactions between masculinizing hormone therapy and oral pre-exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open-label pharmacokinetic study in Thailand
Akarin Hiransuthikul, Narukjaporn Thammajaruk, Stephen Kerr, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 17, 2020
Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion
Shui-Shan Lee, Peter L Anderson, Tsz-Ho Kwan, et al.
Pharmacotherapy
|
June 16, 2022
Cumulative tenofovir diphosphate exposure in persons with HIV taking single- vs. multiple-tablet regimens
Ryan P Coyle, Mary Morrow, Samantha MaWhinney, et al.
Page
of 28
Search research articles
Search
Showing results (121-130 of 271) with videos related to
Sort By:
Page
of 28
Journal of Pharmaceutical and Biomedical Analysis
|
September 24, 2013
Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS
Jia-Hua Zheng, Louis A Guida, Caitlin Rower, et al.
Contemporary Clinical Trials
|
July 10, 2026
Life-steps for PrEP nurse-delivered adherence intervention: Protocol for a multisite randomized clinical trial
Marc Puccinelli, Kenneth H Mayer, Juan A Esquivel-Mendoza, et al.
Plos One
|
January 10, 2018
Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial
Sanjiv M Baxi, Eric Vittinghoff, Peter Bacchetti, et al.
Open Forum Infectious Diseases
|
September 29, 2021
Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIV
Jose R Castillo-Mancilla, Mary Morrow, Ryan P Coyle, et al.
AIDS (London, England)
|
June 15, 2021
Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence
Mary Morrow, Samantha MaWhinney, Ryan P Coyle, et al.
Frontiers in Reproductive Health
|
June 11, 2024
Establishing adherence-concentration-efficacy thresholds of TDF-FTC pre-exposure prophylaxis for HIV prevention in African women: a protocol for the Women TDF-FTC Benchmark Study
Linxuan Wu, Matilda Saina, Clare Brown, et al.
Journal of Neurovirology
|
January 9, 2019
Self-initiated continuation of and adherence to HIV pre-exposure prophylaxis (PrEP) after PrEP demonstration project roll-off in men who have sex with men: associations with risky decision making, impulsivity/disinhibition, and sensation seeking
Martin Hoenigl, Erin Morgan, Donald Franklin, et al.
Journal of the International AIDS Society
|
April 8, 2025
Exploring potential drug-drug interactions between masculinizing hormone therapy and oral pre-exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open-label pharmacokinetic study in Thailand
Akarin Hiransuthikul, Narukjaporn Thammajaruk, Stephen Kerr, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 17, 2020
Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion
Shui-Shan Lee, Peter L Anderson, Tsz-Ho Kwan, et al.
Pharmacotherapy
|
June 16, 2022
Cumulative tenofovir diphosphate exposure in persons with HIV taking single- vs. multiple-tablet regimens
Ryan P Coyle, Mary Morrow, Samantha MaWhinney, et al.
Page
of 28